Location History:
- Zaragoza, ES (2019)
- Saragossa, ES (2017 - 2023)
Company Filing History:
4 out of 45 
3 out of 3 
3 out of 3 Years Active: 2017-2023
Title: Isolda Casanova Rigat: Innovator in Targeted Therapeutics
Introduction
Isolda Casanova Rigat is a prominent inventor based in Saragossa, Spain. She has made significant contributions to the field of targeted therapeutics, holding a total of four patents. Her work focuses on developing methods and reagents for the efficient delivery of therapeutic molecules to specific cells, particularly those expressing the CXCR4 receptor.
Latest Patents
Among her latest patents, Isolda has developed conjugates that comprise a targeting moiety specific for the CXCR4 receptor. These conjugates are based on a polyphemusin-derived peptide and are designed to deliver therapeutic or imaging agents effectively. The patents also include therapeutic and diagnostic methods that require specific targeting to CXCR4+ cells, showcasing her innovative approach to addressing complex medical challenges.
Career Highlights
Isolda has worked with esteemed institutions such as Universitat Autonoma de Barcelona and Institut Recerca Hospital de la Santa Creu i Sant Pau. Her career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Isolda has collaborated with notable colleagues, including Antonio Pedro Villaverde Corrales and Neus Ferrer Miralles. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.
Conclusion
Isolda Casanova Rigat stands out as a key figure in the realm of targeted therapeutics. Her patents and collaborations highlight her dedication to improving therapeutic delivery systems, making a lasting impact on medical research and treatment methodologies.